Index 
 Précédent 
 Suivant 
 Texte intégral 
Procédure : 2018/2775(RSP)
Cycle de vie en séance
Cycle relatif au document : B8-0071/2019

Textes déposés :

B8-0071/2019

Débats :

PV 12/02/2019 - 24
CRE 12/02/2019 - 24

Votes :

PV 13/02/2019 - 16.11
CRE 13/02/2019 - 16.11
Explications de votes

Textes adoptés :

P8_TA(2019)0113

Débats
Mercredi 13 février 2019 - Strasbourg Edition révisée

16.11. Utilisation du cannabis à des fins médicales (B8-0071/2019) (vote)
Vidéo des interventions
PV
 

- Prima della votazione sull'emendamento 11:

 
  
MPphoto
 

  Luke Ming Flanagan (GUE/NGL). – Mr President, the reason for the oral amendment is we have left two members of the cannabis family out of what should have been there. It should also include cannabis indica and cannabis ruderalis. Cannabis ruderalis has very low amounts of tetrahydrocannabinol (THC) in comparison to cannabidiol, which is what some people want here and cannabis indica has a better balance of cannabidiol with THC, so if you want to do it right, include this.

 
  
MPphoto
 

  Dubravka Šuica, on behalf of the PPE Group. – Mr President, on behalf of the PPE Group, I object to this oral amendment.

 
  
 

(L'emendamento orale non è accolto vista l'opposizione di oltre 40 deputati presenti in aula)

 
Dernière mise à jour: 24 mai 2019Avis juridique - Politique de confidentialité